Mitratapide

Mitratapide is a drug that is used in veterinary medicine to treat obesity in dogs. It works by inhibiting the absorption of dietary fats in the intestines, which leads to a reduction in body weight. Mitratapide is marketed under the brand name Yarvitan.

Etymology

The name "Mitratapide" is derived from the Greek words "mitra", meaning "belt", and "tapide", meaning "fat". This is in reference to the drug's ability to reduce body fat.

Pharmacology

Mitratapide is a microsomal triglyceride transfer protein (MTP) inhibitor. MTP is a protein that is essential for the assembly and secretion of lipoproteins in the body. By inhibiting MTP, Mitratapide reduces the absorption of dietary fats in the intestines, leading to a reduction in body weight.

Uses

Mitratapide is used in veterinary medicine to treat obesity in dogs. It is marketed under the brand name Yarvitan. The drug is administered orally, and the dosage is determined by the dog's body weight.

Side Effects

Possible side effects of Mitratapide include vomiting, diarrhea, and loss of appetite. In rare cases, the drug can cause liver damage.

Related Terms

• Obesity in dogs
• Microsomal triglyceride transfer protein
• Lipoproteins
• Yarvitan

Mitratapide Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski